Keeping you up to date with the latest exciting advances and discussions in nephrology

Issue 1 - in focus

See below to revisit the Issue 1 ‘In focus’ section

  • Clinical challenges in kidney disease management
  • What are the barriers to optimising clinical care across the CKD continuum?

Images are not of real patients

Vifor Pharma’s commitment to nephrology

Want to learn more about Vifor Pharma’s Nephrology Portfolio?

This video, first shown at the 58th ERA-EDTA Congress (5–8 June 2021), highlights how Vifor Pharma strives to improve the lives of people suffering from conditions affecting their kidneys, through a broad, innovative nephrology portfolio and individualised solutions.

References and footnotes


AAV, anti-neutrophil cytoplasmic auto-antibody-associated vasculitis; CKD, chronic kidney disease; CKD-aP, chronic kidney disease-associated pruritus; CKD-MBD, chronic kidney disease-mineral bone disorder.